Insider Holders & Insider Ownership - IMMUNE PHARMACEUTICALS INC (IMNPQ)

List of insiders holdings for IMMUNE PHARMACEUTICALS INC:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
Teper Daniel Gedeon
CEO
10% Owner
2016-10-11 18:10:046,050,753
0
6,050,753Form 4
TVM III Limited Partnership
TVM Techno Venture Management No. III Limited Partnership
10% Owner
2007-02-14 15:22:304,559,328
0
4,559,328Form 13G
TVM IV GMBH & CO KG
TVM IV Management GmbH & Co. KG
10% Owner
2006-01-05 14:33:153,408,464
0
3,408,464Form 3
Merlin General Partner II LTD
Merlin Biosciences Fund L.P.
Merlin Biosciences Fund GbR
Member 13G Group - see Remarks
10% Owner
2006-01-04 17:25:120
2,461,928
2,461,928Form 3
Private Equity Direct Finance
10% Owner
2006-01-04 17:27:392,115,343
0
2,115,343Form 3
Kimball Ranch C
Director
2017-02-03 16:02:161,800,000
0
1,800,000Form 4
Luchi Monica E.
EVP & CMO
2016-08-04 21:41:50777,778
0
777,778Form 4
Kazado Daniel
Director
2017-01-27 19:13:06740,000
0
740,000Form 4
DUNTON ALAN W
Director
2013-08-14 17:38:30705,000
0
705,000Form 4
Paley Jeffrey
Director
2017-01-27 19:15:48700,000
0
700,000Form 4
Durrant Cameron
Director
2017-01-27 19:12:28690,000
0
690,000Form 4
Neczesny John A.
Director
2017-01-27 19:15:03640,000
0
640,000Form 4
Ben-Ami Miri
See Remarks
2016-06-03 16:53:58580,000
0
580,000Form 4
Savage Robert G.
Director
2013-08-14 17:50:02475,300
0
475,300Form 4
ALLARD STEPHANE
Chief Medical Officer
2012-12-28 15:37:21414,180
3,333
417,513Form 4
Brownlie Keith L
Director
2013-08-14 17:45:39360,000
0
360,000Form 4
Tseng Ben
Chief Scientific Officer
2009-01-07 16:49:49329,291
0
329,291Form 4
Militello John
See Remarks
2016-06-03 16:06:24320,000
0
320,000Form 4
Talley John V.
President, CEO and Director
2011-01-19 17:10:19300,000
0
300,000Form 4
Chen Michael
VP-Global Business Development
2009-02-24 20:19:30263,560
0
263,560Form 4
Bedard John F.
Director
2008-07-02 10:14:17249,562
0
249,562Form 4
Maza Elliot M
Interim CEO
2017-07-20 20:52:25162,000
0
162,000Form 4
BHAGWAT DILEEP
Senior VP - Pharma. Devel.
2011-01-19 17:20:15100,000
0
100,000Form 4
Damask Michael C
Chief Medical Officer
2006-07-27 12:40:54100,000
0
100,000Form 3
Cook Robert W.
CFO and Senior VP
2014-02-05 12:36:08100,000
0
100,000Form 4
Berdugo Gad
CFO & SVP
2015-05-12 17:17:30100,000
0
100,000Form 4
SIDRANSKY DAVID
Director
2015-01-12 17:16:3671,699
0
71,699Form 4
De Kergrohen Herve
Director
2013-08-27 17:33:0671,419
0
71,419Form 4
Smyth A. Collier
Director
2012-06-25 11:11:5460,000
0
60,000Form 4
Yetter Wayne P.
Director
2012-06-25 11:19:2660,000
0
60,000Form 4
Waldheim Gerhard
Director
2012-06-25 11:15:4460,000
0
60,000Form 4
Stancic Ana
Director
2015-01-12 17:10:4650,000
0
50,000Form 4
LERER RENE
Director
2015-01-12 17:08:5150,000
0
50,000Form 4
AZRIA RENE PIERRE
Director
2015-09-16 17:17:5650,000
0
50,000Form 4
Jackson Guy C.
Director
2010-06-07 14:30:5835,000
0
35,000Form 4
Albouy Pierre
Director
2013-08-27 17:23:1029,758
0
29,758Form 4
Lockhart Earle
VP - Clinical & Reg Affairs
2006-01-09 16:15:0128,125
0
28,125Form 4
Elefant Dov
Controller - VP - Fin & Admin
2006-01-09 16:13:1528,125
0
28,125Form 4
Wiedemann Oliver
see remarks
2011-01-12 18:28:1225,000
0
25,000Form 4
McClurg Michael
VP - Bus Dvlpmnt - Oncology
2006-01-10 12:25:4320,000
0
20,000Form 4
Clark John P
See Remarks
2018-11-20 09:57:1120,000
0
20,000Form 3
Tyrrell Bernard R
Senior VP - Sales & Marketing
2010-02-12 18:42:2912,500
0
12,500Form 4
Kobrin Isaac
Director
2014-06-25 16:10:552,400
0
2,400Form 4
Caspritz Gert
Director
2008-10-08 11:59:290
0
0Form 5
Fiorino Anthony S.
Director
2020-02-04 11:45:530
0
0Form 4